BENLYSTA is for intravenous infusion only and must be reconstituted and diluted prior to administration [see Preparation Of Solutions]. Do not administer as an intravenous push or bolus.
The recommended dosage regimen is 10 mg/kg at 2-week intervals for the first 3 doses and at 4-week intervals thereafter. Reconstitute, dilute, and administer as an intravenous infusion only, over a period of 1 hour. The infusion rate may be slowed or interrupted if the patient develops an infusion reaction. The infusion must be discontinued immediately if the patient experiences a serious hypersensitivity reaction [see CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS].
Prior to dosing with BENLYSTA, consider administering premedication for prophylaxis against infusion reactions and hypersensitivity reactions [see WARNINGS AND PRECAUTIONS, ADVERSE REACTIONS].
BENLYSTA is provided as a lyophilized powder in a single-dose vial for intravenous infusion only and should be reconstituted and diluted by a healthcare professional using aseptic technique as follows. Use of a 21-to 25-gauge needle is recommended when piercing the vial stopper for reconstitution and dilution.
